Literature DB >> 15538733

The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome.

Hitoshi Hirata1, Takeshi Nagakura, Masaya Tsujii, Akimasa Morita, Kohzo Fujisawa, Atsumasa Uchida.   

Abstract

Tenosynovial thickening within the confined space of the carpal tunnel is thought to be the cause of the carpal tunnel syndrome (CTS). However, little is known about the pathological mechanism of tenosynovial thickening. In this study, the role of prostaglandin E(2) (PGE(2)) and vascular endothelial growth factor (VEGF) (two representative molecules that can induce oedema by increasing vascular permeability) was analysed in CTS by using immunohistochemistry and enzyme-linked immunosorptive assay (ELISA). Expression of these molecules was compared with the patients' clinical histories and a temporary increase in production of these molecules was found in cells within the vessels and synovial lining during the intermediate phase of the syndrome when the histology of the tenosynovium changes from oedematous to fibrotic. Statistical analysis clearly demonstrated that there is a close correlation between the expression of PGE(2) and VEGF. Furthermore, immunohistochemical analysis with anti-proliferating cell nuclear antigen (PCNA) revealed that the area with distinct VEGF expression closely matched the area where endothelial cells, vascular smooth muscle cells, and synovial lining cells proliferate. In contrast, despite marked alteration in the extracellular matrix (ECM) component of the tenosynovium, the fibroblasts responsible for most ECM framework production do not proliferate during any phase of CTS. Histological analysis demonstrated that angiogenesis takes place only during the intermediate phase. Since clusters of capillaries and arterioles are often surrounded by type III collagen-rich, disorganized, degenerate connective tissue, which contains fewer fibroblasts than normal, angiogenesis appears to take place as a part of a regenerative reaction that results in fibrosis. These findings strongly indicate that both PGE(2) and VEGF are expressed in the tenosynovium in CTS during the intermediate phase and induce the histological changes seen in the tenosynovium. Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538733     DOI: 10.1002/path.1673

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  24 in total

1.  Low-level laser in the treatment of carpal tunnel syndrome: clinical, electrophysiological, and ultrasonographical evaluation.

Authors:  Funda Tascioglu; Nevbahar Akcar Degirmenci; Serhat Ozkan; Ozlem Mehmetoglu
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 2.  Impact of mechanical stretch on the cell behaviors of bone and surrounding tissues.

Authors:  Hye-Sun Yu; Jung-Ju Kim; Hae-Won Kim; Mark P Lewis; Ivan Wall
Journal:  J Tissue Eng       Date:  2015-12-29       Impact factor: 7.813

3.  Subsynovial connective tissue is sensitive to surgical interventions in a rabbit model of carpal tunnel syndrome.

Authors:  Yu-Long Sun; Tamami Moriya; Chunfeng Zhao; Ramona L Kirk; Takako Chikenji; Sandra M Passe; Kai-Nan An; Peter C Amadio
Journal:  J Orthop Res       Date:  2011-10-18       Impact factor: 3.494

4.  Transforming growth factor-β (TGF-β) expression is increased in the subsynovial connective tissues of patients with idiopathic carpal tunnel syndrome.

Authors:  Takako Chikenji; Anne Gingery; Chunfeng Zhao; Sandra M Passe; Yasuhiro Ozasa; Dirk Larson; Kai-Nan An; Peter C Amadio
Journal:  J Orthop Res       Date:  2013-09-09       Impact factor: 3.494

Review 5.  Efficacy of low-level laser therapy in carpal tunnel syndrome management: a systematic review and meta-analysis.

Authors:  Amira Hassan Bekhet; Basma Ragab; Abdelrahman Ibrahim Abushouk; Ahmed Elgebaly; Olfat Ibrahim Ali
Journal:  Lasers Med Sci       Date:  2017-06-05       Impact factor: 3.161

6.  Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome.

Authors:  Moaz A Mojaddidi; Mohammed S Ahmed; Razwan Ali; Maria Jeziorska; Ahmed Al-Sunni; Niels O B Thomsen; Lars B Dahlin; Rayaz A Malik
Journal:  Diabetologia       Date:  2014-05-28       Impact factor: 10.122

7.  Treatment of carpal tunnel syndrome by low-level laser versus open carpal tunnel release.

Authors:  Tarek F Elwakil; Alaa Elazzazi; Hisham Shokeir
Journal:  Lasers Med Sci       Date:  2007-03-03       Impact factor: 3.161

8.  Evaluation of the material properties of the subsynovial connective tissue in carpal tunnel syndrome.

Authors:  Naoki Osamura; Chunfeng Zhao; Mark E Zobitz; Kai-Nan An; Peter C Amadio
Journal:  Clin Biomech (Bristol, Avon)       Date:  2007-09-05       Impact factor: 2.063

9.  Manual therapy as an effective treatment for fibrosis in a rat model of upper extremity overuse injury.

Authors:  Geoffrey M Bove; Michele Y Harris; Huaqing Zhao; Mary F Barbe
Journal:  J Neurol Sci       Date:  2015-12-24       Impact factor: 3.181

10.  Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury.

Authors:  Jane M Fedorczyk; Ann E Barr; Shobha Rani; Helen G Gao; Mamta Amin; Shreya Amin; Judith Litvin; Mary F Barbe
Journal:  J Orthop Res       Date:  2010-03       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.